4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001415889-25-005368
Options or other derivatives
- CEO acquired 1,650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| LEVIN JEREMY M CEO | 2025-02-20 | Grant or award · Employee Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | D | ||
Loading xslF345X05/form4-02242025_070206.xml…